Symbiosis Marks Milestone with 1,000th Sterile Drug Manufacturing Batch
A significant highlight in its journey was its contribution to the development of the Oxford University/AstraZeneca COVID-19 vaccine, where the company produced nearly one million doses at its Stirling facility to support clinical trials and regulatory approvals in the UK.
Symbiosis Pharmaceutical Services, A Global Contra | 31/07/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy